Metabolomics-based multidimensional network biomarkers for diabetic retinopathy identification in patients with type 2 diabetes mellitus

INTRODUCTION: Despite advances in diabetic retinopathy (DR) medications, early identification is vitally important for DR administration and remains a major challenge. This study aims to develop a novel system of multidimensional network biomarkers (MDNBs) based on a widely targeted metabolomics app...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Jingjing, Lan, Yuan, Hu, Honglin, Hou, Xiangqing, Li, Jushuang, Wang, Tao, Zhang, Hang, Zhang, Nana, Guo, Chengnan, Peng, Fang, Zhao, Shuzhen, Wei, Yaping, Jia, Chaonan, Zheng, Chao, Mao, Guangyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Genetics/Genomes/Proteomics/Metabolomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888330/
https://www.ncbi.nlm.nih.gov/pubmed/33593748
http://dx.doi.org/10.1136/bmjdrc-2020-001443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888330/
https://www.ncbi.nlm.nih.gov/pubmed/33593748
http://dx.doi.org/10.1136/bmjdrc-2020-001443

Ejemplares similares